Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW.

J Clin Endocrinol Metab. 1997 Dec;82(12):4196-200.

PMID:
9398739
2.

The angiotensin-converting enzyme gene and the angiotensin II type I receptor gene as candidate genes for microalbuminuria. A study in nondiabetic and non-insulin-dependent diabetic subjects.

Yudkin JS, Andres C, Mohamed-Ali V, Gould M, Panahloo A, Haines AP, Humphries S, Talmud P.

Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2188-91.

3.

Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy.

Roy S, McGuire W, Mascie-Taylor CG, Saha B, Hazra SK, Hill AV, Kwiatkowski D.

J Infect Dis. 1997 Aug;176(2):530-2.

PMID:
9237725
4.

Polymorphisms of the interleukin-6 gene are associated with bone mineral density.

Murray RE, McGuigan F, Grant SF, Reid DM, Ralston SH.

Bone. 1997 Jul;21(1):89-92.

PMID:
9213013
5.
6.
7.

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195-9.

8.

A greater variability in the 3' flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE).

Linker-Israeli M, Wallace DJ, Prehn JL, Nand R, Li L, Klinenberg JR.

Autoimmunity. 1996;23(3):199-209.

PMID:
8879455
9.

Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis.

De Benedetti F, Pignatti P, Massa M, Sartirana P, Ravelli A, Martini A.

Clin Exp Rheumatol. 1995 Nov-Dec;13(6):779-84.

PMID:
8835254
10.

Dynamics of fever and the cytokine network in systemic juvenile arthritis.

Prieur AM, Roux-Lombard P, Dayer JM.

Rev Rhum Engl Ed. 1996 Mar;63(3):163-70.

PMID:
8731233
11.

Microalbuminuria: associations with height and sex in non-diabetic subjects.

Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP.

BMJ. 1993 Jan 23;306(6872):240-2.

13.

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J, et al.

Arthritis Rheum. 1993 Dec;36(12):1681-90.

PMID:
8250987
14.

Deletion of the retinoblastoma gene in multiple myeloma.

Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G.

Leukemia. 1994 Aug;8(8):1280-4.

PMID:
8057662
15.
16.

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D.

Nature. 1994 Oct 6;371(6497):508-10.

PMID:
7935762
18.
19.

A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism.

McDowell TL, Symons JA, Ploski R, Førre O, Duff GW.

Arthritis Rheum. 1995 Feb;38(2):221-8.

PMID:
7848312
20.

Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.

Mangge H, Kenzian H, Gallistl S, Neuwirth G, Liebmann P, Kaulfersch W, Beaufort F, Muntean W, Schauenstein K.

Arthritis Rheum. 1995 Feb;38(2):211-20.

PMID:
7848311

Supplemental Content

Support Center